ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
마약 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보일 것으로 예상되며, 2029년에는 177억 9,000만 달러에 달할 것으로 예상되며, 연평균 4.6%의 연평균 성장률(CAGR)을 보일 것입니다. 이 예측 기간의 성장은 제네릭 의약품에 대한 수요 증가, 제약 산업의 성장, 최소침습 수술에 대한 수요 증가, 완화 치료에서 마약의 사용 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 의약품 기술 혁신, 원격의료 및 원격 모니터링, 비오피오이드 대체 약물 개발, 인공지능(AI)의 신약 개발 및 신약 개발 활용 등이 있습니다.
마약 시장의 성장은 만성질환의 유병률 증가에 의해 견인될 것으로 예상됩니다. 만성질환은 3개월 이상 지속되고 시간이 지남에 따라 악화되는 질병으로 정의됩니다. 마약은 암, 만성 통증 증후군, 말기 질환, 중증 관절염으로 고통받는 환자들을 구제하고 이러한 질환을 관리하는 데 중요한 역할을 하고 있습니다. 예를 들어, 2024년 6월 영국 정부 기관인 National Health Service는 2023년 영국에서 50만 명 이상(549,000명)이 제2형 당뇨병에 걸릴 위험이 있는 것으로 확인되었다고 보고했습니다. 이에 따라 GP에 등록된 비당뇨병성 고혈당 또는 예비 당뇨병 환자 수는 총 3,615,330명으로 2022년 3,065,825명에서 20% 가까이 증가했습니다. 결과적으로 만성질환의 유병률 증가가 마약 시장의 성장을 주도하고 있습니다.
마약 시장의 성장은 처방약으로서의 오피오이드 사용 증가로 인해 큰 영향을 받을 것으로 예상됩니다. 오피오이드는 합법적인 처방약과 불법 약물을 모두 포함하는 약물군으로, 행복감, 이완감, 안정감을 유발하는 것으로 알려져 있습니다. 오피오이드는 강력한 진통 및 진정 효과로 인해 특히 다른 통증 관리 방법이 충분하지 않을 때 사용되기 때문입니다. 예를 들어, 2024년 5월 호주 정부 기관인 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 2023년 어느 날 호주(서호주 제외)에서 오피오이드 의존증으로 약물 치료를 받고 있는 사람이 있는 사람이 53,272명이라고 보고했습니다. 이처럼 처방약으로 오피오이드의 사용이 증가하고 있는 것이 마약 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 마약 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
최종 이용 산업 분석
세계의 마약 시장 : 성장률 분석
세계의 마약 시장 실적 : 규모와 성장, 2019-2024
세계의 마약 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 마약 전체 시장(TAM)
제6장 시장 세분화
세계의 마약 시장 : 약물별 실적과 예측, 2019-2024, 2024-2029F, 2034F
아편
헤로인
코데인
옥시코돈
기타 약물
세계의 마약 시장 : 소스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
천연
반합성
합성
세계의 마약 시장 : 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
통증 관리
기침
설사
이질
천식
기타 적응증
세계의 마약 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
온라인 약국
소매 약국
세계의 마약 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 마약 시장, 헤로인 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
디아세틸 모르핀
헤로인 염산염
헤로인 아세테이트
세계의 마약 시장, 코데인 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
코데인 인산염
코데인 황산염
세계의 마약 시장, 옥시코돈 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
옥시코돈 염산염
옥시코돈 아세트아미노펜
서방형 옥시코돈
세계의 마약 시장, 기타 의약품 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
펜타닐
모르핀
하이드로모폰
메타돈
부프레노르핀
제7장 지역별·국가별 분석
세계의 마약 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 마약 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
마약 시장 : 경쟁 구도
마약 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson and Johnson Limited Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Boehringer Ingelheim International GmbH
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Daiichi Sankyo Company Limited
Sun Pharmaceutical Industries Ltd.
Purdue Pharma LP
Hikma Pharmaceuticals Plc
Endo Pharmaceuticals Inc.
Amneal Pharmaceuticals LLC
Lupin Ltd.
Mallinckrodt Pharmaceuticals
Alvogen Inc.
Indivior Inc.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
마약 시장 2029 : 새로운 기회를 제공하는 국가
마약 시장 2029 : 새로운 기회를 제공하는 부문
마약 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
A narcotic drug is a class of substances that affect the central nervous system, inducing effects like drowsiness, pain relief, euphoria, and sometimes hallucinations. These drugs are commonly derived from the opium poppy plant but can also be synthesized.
The key types of narcotic drugs include opium, heroin, codeine, oxycodone, and others. Opium is a bitter, brownish, addictive substance derived from the dried latex of immature seed capsules of the opium poppy. These narcotics come from various sources, which can be natural, semi-synthetic, or synthetic, and are used for a range of purposes, including pain management, cough suppression, diarrhea treatment, asthma relief, and more. They are distributed through a variety of channels, including hospital pharmacies, online pharmacies, and retail pharmacies, and are utilized by diverse end-users, such as hospitals, homecare services, specialty clinics, and others.
The narcotic drugs market research report is one of a series of new reports from The Business Research Company that provides narcotic drugs market statistics, including narcotic drugs industry global market size, regional shares, competitors with a narcotic drugs market share, detailed narcotic drugs market segments, market trends and opportunities and any further data you may need to thrive in the narcotic drugs industry. This narcotic drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The narcotic drugs market size has grown steadily in recent years. It will grow from $14.26 billion in 2024 to $14.85 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to increasing medical need, growing public health concerns, increasing access to healthcare, rising prevalence of chronic pain, government initiatives to improve pain management.
The narcotic drugs market size is expected to see steady growth in the next few years. It will grow to $17.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to growing demand for generic narcotic drugs, growing pharmaceutical industry, growing demand for minimally invasive surgeries, increased use of narcotic drugs in palliative care. Major trends in the forecast period include pharmaceutical innovation, telemedicine and remote monitoring, development of non-opioid alternatives, use of artificial intelligence (AI) in drug discovery and development.
The growth of the narcotic drug market is anticipated to be driven by the increasing incidence of chronic diseases. Chronic diseases are defined as illnesses lasting three months or more that can worsen over time. Narcotic drugs play a crucial role in managing these conditions, offering relief for patients suffering from cancer, chronic pain syndrome, terminal illnesses, and severe arthritis. For example, in June 2024, the National Health Service, a UK-based government agency, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330, marking a significant increase from 3,065,825 in 2022, which is nearly a 20% rise. Consequently, the increasing prevalence of chronic diseases is driving the growth of the narcotic drug market.
The growth of the narcotic drugs market is expected to be significantly influenced by the rising use of opioids as prescription medications. Opioids are a class of drugs that encompass both legal prescriptions and illegal substances, known for inducing feelings of euphoria, relaxation, and sedation. Their increasing use in prescription medicine is a key driver of narcotic drug consumption, as opioids are valued for their powerful pain-relieving and sedative effects, particularly when other pain management methods prove inadequate. For example, in May 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that on a specific day in 2023, there were 53,272 individuals undergoing pharmacotherapy for opioid dependence in Australia (excluding Western Australia), translating to a rate of 22 clients per 10,000 people. Thus, the growing use of opioids as prescription medications is propelling the growth of the narcotic drugs market.
Prominent companies within the narcotic drug market are placing a growing emphasis on product development and innovation to offer dependable products to their customers and bolster their positions in the market. As an example, in May 2023, Indivior PLC, a pharmaceutical company headquartered in the United States, introduced OPVEE (nalmefene) nasal spray. This product serves as an opioid overdose rescue medication designed for use with natural and synthetic opioids, including substances like fentanyl. It is recommended for immediate use in the treatment of known or suspected opioid overdoses in adults and pediatric patients aged 12 and older, particularly in cases involving respiratory and central nervous system depression. This development underscores the company's commitment to addressing critical medical needs and enhancing the safety of individuals at risk of opioid overdose.
In March 2023, Indivior PLC, a pharmaceutical company based in the United States, completed its acquisition of Opiant Pharmaceuticals Inc. for a total of $145 million. This strategic acquisition is intended to bolster Indivior PLC's portfolio in the field of addiction treatment and science. It is noteworthy that this acquisition includes OPNT003, an investigational opioid overdose treatment, which is seen as a crucial addition to address the ongoing opioid overdose crisis in the United States, particularly involving potent synthetic opioids like fentanyl. Opiant Pharmaceuticals Inc., a pharmaceutical company headquartered in the United States, specializes in the manufacturing of narcotic drugs. This acquisition reflects Indivior PLC's commitment to expanding its offerings in the fight against opioid overdoses and substance use disorders.
Major companies operating in the narcotic drugs market are Pfizer Inc., Johnson and Johnson Limited, AbbVie Inc., Novartis AG, AstraZeneca PLC, Sanofi S.A., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma LP, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Lupin Ltd., Mallinckrodt Pharmaceuticals, Alvogen Inc., Indivior Inc., Impax Laboratories Inc., Collegium Pharmaceutical Inc., Lannett Co Inc., Par Pharmaceutical Inc., West-Ward Pharmaceuticals Corp.
Asia-Pacific was the largest region in the narcotic drugs market in 2024. The regions covered in the narcotic drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The countries covered in the narcotic drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.
The narcotic drug market consists of sales of ketobemidone, pethidine, tolidine, and trimeperidine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Narcotic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on narcotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for narcotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The narcotic drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug: Opium; Heroin; Codeine; Oxycodone; Other Drugs
2) By Source: Natural; Semi-Synthetic; Synthetic
3) By Indication: Pain Management; Cough; Diarrhea; Dysentery; Asthma; Other Indications
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
Subsegments:
1) By Opium: Raw Opium; Opium Extracts; Opium Derivatives
2) By Heroin: Diacetylmorphine; Heroin Hydrochloride; Heroin Acetate
3) By Codeine: Codeine Phosphate; Codeine Sulfate
4) By Oxycodone: Oxycodone Hydrochloride; Oxycodone Acetaminophen; Controlled-Release Oxycodone
5) By Other Drugs: Fentanyl; Morphine; Hydromorphone; Methadone; Buprenorphine
Companies Mentioned: Pfizer Inc.; Johnson and Johnson Limited; AbbVie Inc.; Novartis AG; AstraZeneca PLC
